Cochrane Abstracts
Intermittent versus continuous androgen suppression for prostatic cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intermittent Versus Continuous Androgen Suppression for Prostatic Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435483/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer.
Intermittent versus continuous androgen suppression for prostatic cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435483/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer. Accessed November 26, 2024.
Intermittent versus continuous androgen suppression for prostatic cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435483/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer
Intermittent Versus Continuous Androgen Suppression for Prostatic Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435483/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intermittent versus continuous androgen suppression for prostatic cancer
ID - 435483
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435483/all/Intermittent_versus_continuous_androgen_suppression_for_prostatic_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
